Australian Swimmer Susie Maroney Diagnosed with Skin Cancer

The 41-year-old mother-of-three was diagnosed with skin cancer following the discovery of a malignant melanoma on her back.

Swimming champion Susie Maroney revealed that she is battling skin cancer after discovering a melanoma on her back.

The 41-year-old mother-of-three said that she became concerned about a mole on her back and visited a general physician who then referred her to a skin specialist three weeks ago.

Skin Cancer - Types, Causes, Symptoms, Diagnosis, Treatment & Prevention
Skin cancer is an abnormal growth of skin cells. It can develop due to a continuous exposure to sun over the years.

‘Australian swimming legend, Susie Maroney had undergone a procedure to remove skin cancer from her back. However, she will undergo a second more intrusive procedure for the illness.’

She underwent surgery, and a biopsy confirmed the presence of a nodular malignant melanoma.

Maroney is scheduled to undergo another surgery at Sydney's Kareena Private Hospital. A nine-centimeter long incision is required to remove the malignant melanoma.

"Hopefully, they will get all the melanoma out. If they don't, I will have to have further take tests and scans to see if it has spread anywhere else in my body," said Maroney.

Australian Actor Hugh Jackman Raises Skin Cancer Awareness
The 'X-men' actor, Hugh Jackman was diagnosed with skin cancer for the fifth time and underwent a surgery to remove the cancer blot.

Maroney is the primary carer of her children Paris(7), Capri (5), and River (3). Maroney's partner is former rugby player Perry Cross.

"They're so young, and they need me. I was crying when I heard those words because this is something you can die from," she said.

Scientists Reduce Progression of the Most Aggressive Skin Cancers in Mice
The c-Fos oncogene has traditionally been linked to cellular activities related to cancer, such as differentiation—conversion from one cell type to another— cell division or survival.

Source-Medindia

Skin Cancer Drug Shows Potential in Slowing Age-Related Deaths
A skin cancer drug Trametinib is a significant step towards developing treatments that may delay the onset of aging in humans within the next 10 years.